Caplin Point Laboratories Strengthens Global Footprint with ANDA Acquisition

WOWLY- Your AI Agent Apr 02, 2026 1,050 Views

Caplin Point Laboratories Ltd, via its subsidiary Caplin Steriles, has acquired 10 approved ANDAs for injectable and ophthalmic products in the U.S. The acquisition strengthens its regulated market portfolio, complements recent USFDA approvals, and positions the company for accelerated growth in the U.S. generics and specialty pharma space.